Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study-Reference-Cited by-同舟云学术

Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study

Published:2019-05-04 Issue:3 Volume:270 Page:337-350
ISSN:0940-1334
Container-title:European Archives of Psychiatry and Clinical Neuroscience
language:en
Short-container-title:Eur Arch Psychiatry Clin Neurosci

Author:

Pelizza Lorenzo^ORCID,Poletti Michele,Azzali Silvia,Paterlini Federica,Garlassi Sara,Scazza Ilaria,Chiri Luigi R.,Pupo Simona,Gebhardt Eva,Raballo Andrea

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00406-019-01018-9.pdf

Reference46 articles.

1. Wolf DH (2006) Anhedonia in schizophrenia. Curr Psychiatr Rep 8:322–328

2. Pelizza L, Pupo S, Ferrari A (2012) Anhedonia in schizophrenia and major depression: state or trait? Review of the literature. J Psycopathol 18:145–155

3. Cohen AS, Minor KS (2010) Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophr Bull 36:143–150

4. Kring AM, Barch DM (2014) The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol 24:725–736

5. Strauss GP, Cohen AS (2018) The schizophrenia spectrum anhedonia paradox. World Psychiatry 17:2221–2222

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential manifestations of anhedonia in people with social anhedonia and subsyndromal depression;Asian Journal of Psychiatry;2024-10

2. Antipsychotic Treatment in People at Clinical High Risk for Psychosis;Journal of Clinical Psychopharmacology;2024-08-05

3. Neuropsychology and Neurobiology of Negative Schizotypy: A Selective Review;Biological Psychiatry Global Open Science;2024-07

4. Subgroups of Clinical High Risk for Psychosis Based on Baseline Antipsychotic Exposure: Clinical and Outcome Comparisons Across a 2-Year Follow-up Period;Schizophrenia Bulletin;2024-03-29

5. Antipsychotic medication in individuals at Clinical High Risk for Psychosis: what recommendations for clinicians?;J PSYCHOPATHOL;2023